The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 18.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (14 analysts) rates it buy, with a mean price target of $5914. Since the last review it its composite score eased.
Hitachi Ltd
6501.T · TSE · JPY · Market cap $20.94T
Hitachi, Ltd.
PASS · Titan Ethical · score 70.0Screen close, 2026-09-18 · not a live quote
Last reviewed 17 days ago
Screened 2026-09-18 · the tape above runs as of 09:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 5,524.00 against the desk's fair-value range, base estimate 4,467.02, over the last year.
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its accumulation label.
Hitachi Ltd holds its Accumulation at $5,524.00. Consolidating, no directional conviction, held for 3 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 3 days |
| Price at the screen | $5,524.00 |
| Valuation | 31.30 trailing · 31.01 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 0.50 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 9.08% | Below 33% | Interest-bearing debt is just 9.1% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 6.52% | Below 33% | Cash held in interest-bearing accounts and securities is 6.5% of assets, under the one-third limit. | Pass |
| Receivables | 26.32% | Below 49% | Money owed to the company is 26.3% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.27% | Below 5% | Only 0.3% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
Hitachi clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 9%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-04. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades above our $4,467.02 fair value estimate, 11.30% revenue growth.
Fair value range in JPY, drawn from the 2026-09-18 screen. The gold marker is the market price at the same screen. The price runs 19.1% above the base estimate.
Third-party analyst targets: 14 covering, consensus Buy. The average target sits +10% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-18 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it gives us pause
At 31.0x forward earnings, the price already runs ahead of the business. It trades 19% above our $4,467.02 fair value, so you would be buying at a premium, not a discount.
| Forward P/E | 31.0xexpensive even after accounting for its growth |
| Trailing P/E | 31.3xa premium valuation |
| EPS, trailing | 176.50 |
| EPS, forward | 178.13 |
| Revenue growth | +11.3%steady growth |
| Profit margin | 7.6%thin but positive margins |
| Return on equity | 13.3%a solid return on shareholder capital |
| FCF yield | 5.15% |
| Dividend yield | 120.00% |
| Debt to equity | 0.15minimal debt: a conservative balance sheet |
| Beta | 0.50barely tracks the market's swings |
| 52-week range | 3,822.00 - 6,039.00 |
| Market cap | $20.94T |
The risks · The things to watch: its business and earnings are exposed to Japan and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade6501.T trades on TSE (the company is based in Japan). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (14 analysts) rates it buy, with a mean price target of $5914.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (14 analysts) rates it buy, with a mean price target of $5914.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (14 analysts) rates it buy, with a mean price target of $5914.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (14 analysts) rates it buy, with a mean price target of $5914.
5 July 2026 — ¥4,657 — MARKDOWN (state model: sideways, 253 days). Journal opened on the morning after the great re-rating: 186.8% three-year run, now 23% off the high with every recent column mildly red. Tensions on file: an operating story that never stopped (11.3% growth, screen pass, street at ¥6,100), against a finished multiple story. The lines: ¥4,784 above, ¥3,822 below. Next review: the state committing or a line breaking, whichever is first.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $4,887.00 | -2.1% | · | $979 | -2.1% |
| 2 months | $4,810.00 | -0.5% | · | $995 | -0.5% |
| 3 months | $4,897.80 | -2.3% | $27.00 | $982 | -1.8% |
| 6 months | $4,981.32 | -4.0% | $27.00 | $966 | -3.4% |
| 1 year | $4,041.85 | +18.4% | $50.00 | $1,196 | +19.6% |
| 2 years | $3,352.72 | +42.7% | $93.00 | $1,455 | +45.5% |
| 3 years | $1,668.37 | +186.8% | $129.00 | $2,945 | +194.5% |
| 5 years | $1,105.66 | +332.7% | $183.00 | $4,492 | +349.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever 6501.T does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.